Peripheral Immune System Activity in Temporal Lobe Epilepsy Correlates with NODDI Multi-Compartment

Poster No:

78 

Submission Type:

Abstract Submission 

Authors:

Jerzy Szaflarski1, Rodolphe Nenert1, Huixian Hong1, Christina Mueller1, Ayushe Sharma2, Hongwei Qin1, Etty Benveniste1

Institutions:

1University of Alabama at Birmingham, Birmingham, AL, 2Yale University, New Haven, CT

First Author:

Jerzy Szaflarski  
University of Alabama at Birmingham
Birmingham, AL

Co-Author(s):

Rodolphe Nenert, PhD  
University of Alabama at Birmingham
Birmingham, AL
Huixian Hong, MD, PhD  
University of Alabama at Birmingham
Birmingham, AL
Christina Mueller, PhD  
University of Alabama at Birmingham
Birmingham, AL
Ayushe Sharma, PhD  
Yale University
New Haven, CT
Hongwei Qin, MD, PhD  
University of Alabama at Birmingham
Birmingham, AL
Etty Benveniste, PhD  
University of Alabama at Birmingham
Birmingham, AL

Introduction:

Studies of patients with temporal lobe (TLE) and other focal onset epilepsies have shown that neuroinflammation is a contributor to seizure initiation and maintenance. We have recently shown a correlation between peripheral molecular and cellular biomarkers of inflammation and focal increase in temperature in the temporal lobe ipsilateral to seizure onset (i.e., the affected temporal lobe; aTL) in patients with treatment-resistant TLE (Mueller et al., 2024 Epilepsia Open). Here, we use whole-brain diffusion magnetic resonance imaging to identify abnormalities in multicompartment Neurite Orientation Dispersion and Density Imaging (NODDI) measures (FISO (free water), FICVF (neurite density), and ODI (neurite dispersion)) as a non-invasive proxy of neuroinflammation in TLE and examine the relationship between these measures and molecular and cellular biomarkers of peripheral inflammation in TLE. We hypothesize that FISO, FICVF, and ODI changes in the ictal onset zone (aTL) will be associated with these biomarkers.

Methods:

Eighteen patients with scalp video/EEG confirmed TLE and 18 age-matched healthy controls (HCs) underwent 3T MRI high angular resolution diffusion imaging (HARDI) protocol. NODDI FISO, FICVF and ODI statistical maps were generated for each participant. Two-sample t-tests (FDR corrected, p<0.05) were conducted to compare the two groups across these maps, focusing on the temporal region using a previously published binary mask (Sharma et al., 2023 Epilepsia). Peripheral venous blood was collected within <1 hour of imaging for extensive exploratory cellular and molecular biomarker testing. For each significant cluster identified, FISO, FICVF and ODI values were extracted for the TLE group and correlated with the biomarkers of peripheral inflammation.

Results:

Mostly in the aTL, we observed significantly lower FICVF values compared to HCs indicating the expected neurite loss in the affected by epilepsy temporal lobe (Figure). These neurite density losses correlated with several molecular and cellular biomarkers (Table; e.g., granulocyte colony-stimulating factor (G-CSF) suggestive of decreased anti-inflammatory reaction, and vascular endothelial growth factor A (VEGF-A) indicating lower suppression of new vessel formation in aTL) or cellular biomarkers (e.g., decreased association with Breg indicating lower immunomodulation in aTL). We also observed higher ODI and FISO values in the aTL compared to HCs (Figure). Increased ODI and FISO indicate changes in tissue microstructure such as higher dendritic branching and increased extracellular water content, which are the key aspects of neuroinflammation. These changes significantly correlated with numerous molecular and cellular peripheral biomarkers of inflammation (Table). For example, there were positive associations in the aTL with several chemokines responsible for regulating immune responses. However, we also observed a decreased association with IL-6 known to stimulate acute immune responses and be elevated in treatment-resistant TLE. Cellular responses also positively correlated with the structural changes indicating increased peripheral cellular response to aTL inflammatory microstructural changes (or to seizure-induced damage).

Conclusions:

Developing non-invasive procedures to measure neuroinflammation has been a major focus of neuroimaging investigations in epilepsy. Such a technique would allow visualization of abnormal brain regions for possible monitoring of disease course and treatment response. NODDI differences between TLE and HCs mostly localized to the aTL indicate a specific relationship between imaging biomarker of injury/neuroinflammation and cellular/molecular biomarkers of inflammation and support NODDI as a possible measure of neuroinflammation in TLE.

Disorders of the Nervous System:

Neurodegenerative/ Late Life (eg. Parkinson’s, Alzheimer’s) 1

Novel Imaging Acquisition Methods:

Diffusion MRI 2

Physiology, Metabolism and Neurotransmission:

Physiology, Metabolism and Neurotransmission Other

Keywords:

Epilepsy
WHITE MATTER IMAGING - DTI, HARDI, DSI, ETC

1|2Indicates the priority used for review
Supporting Image: Picture1.png
   ·Figure
Supporting Image: Picture2.png
   ·Table
 

Abstract Information

By submitting your proposal, you grant permission for the Organization for Human Brain Mapping (OHBM) to distribute your work in any format, including video, audio print and electronic text through OHBM OnDemand, social media channels, the OHBM website, or other electronic publications and media.

I accept

The Open Science Special Interest Group (OSSIG) is introducing a reproducibility challenge for OHBM 2025. This new initiative aims to enhance the reproducibility of scientific results and foster collaborations between labs. Teams will consist of a “source” party and a “reproducing” party, and will be evaluated on the success of their replication, the openness of the source work, and additional deliverables. Click here for more information. Propose your OHBM abstract(s) as source work for future OHBM meetings by selecting one of the following options:

I do not want to participate in the reproducibility challenge.

Please indicate below if your study was a "resting state" or "task-activation” study.

Other

Healthy subjects only or patients (note that patient studies may also involve healthy subjects):

Patients

Was this research conducted in the United States?

Yes

Are you Internal Review Board (IRB) certified? Please note: Failure to have IRB, if applicable will lead to automatic rejection of abstract.

Yes, I have IRB or AUCC approval

Were any human subjects research approved by the relevant Institutional Review Board or ethics panel? NOTE: Any human subjects studies without IRB approval will be automatically rejected.

Yes

Were any animal research approved by the relevant IACUC or other animal research panel? NOTE: Any animal studies without IACUC approval will be automatically rejected.

Not applicable

Please indicate which methods were used in your research:

Structural MRI
Diffusion MRI

For human MRI, what field strength scanner do you use?

3.0T

Which processing packages did you use for your study?

SPM

Provide references using APA citation style.

Mueller C, Hong H, Sharma A, Qin H, Benveniste EN, Szaflarski JP “Brain temperature, metabolites, and immune phenotypes in temporal lobe epilepsy” accepted for publication, Epilepsia Open 2024; PMID: 39470707

Sharma AA, Nenert R, Goodman AM, Szaflarski JP “Concordance between focal brain temperature elevations and focal edema in temporal lobe epilepsy” Epilepsia 2023, May; 64(5):1289-1304; PMID 36762949

UNESCO Institute of Statistics and World Bank Waiver Form

I attest that I currently live, work, or study in a country on the UNESCO Institute of Statistics and World Bank List of Low and Middle Income Countries list provided.

No